Related Experiment Videos
Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability
R W van Deursen1, M M Sanchez, J A Derr
1Center for Locomotion Studies and Statistical Consulting Center, 29 Recreation Building, Penn State University, University Park, PA 16802, USA.
Summary
The new Maxivibrometer reliably measures vibration perception threshold (VPT) in diabetic neuropathy patients, even with severe nerve damage. This advanced tool overcomes the limitations of the Biothesiometer for comprehensive neuropathy assessment.
Area of Science:
- Neurology
- Biomedical Engineering
- Diabetology
Background:
- Diabetic neuropathy affects a significant portion of diabetic patients, leading to sensory loss.
- Accurate measurement of vibration perception threshold (VPT) is crucial for assessing diabetic neuropathy.
- Existing devices like the Biothesiometer have limitations, particularly with severe neuropathy, leading to off-scale measurements.
Purpose of the Study:
- To evaluate the reliability and performance of a new vibrometer, the Maxivibrometer.
- To compare the Maxivibrometer's ability to measure VPT against the established Biothesiometer.
- To determine the suitability of the Maxivibrometer for assessing VPT across a wide range of neuropathy severity.
Main Methods:
- The Maxivibrometer and Biothesiometer were used to measure VPT on the plantar surface of the feet.
- Testing was conducted on two groups: individuals with diabetic neuropathy and healthy control subjects.
- Reliability was assessed using replication-to-replication and day-to-day intraclass correlation coefficients.
Main Results:
- The Maxivibrometer provided actual VPT measurements for all subjects, including those with severe neuropathy.
- Maxivibrometer demonstrated excellent reliability with intraclass correlation coefficients generally above 0.94.
- The Biothesiometer showed excellent reliability but was limited to measuring mild to moderate neuropathy (ICC=0.93).
Conclusions:
- The Maxivibrometer offers a wider measurement range than the Biothesiometer, accurately quantifying sensory loss in severe diabetic neuropathy.
- Its excellent reliability and broad range make the Maxivibrometer a valuable research tool for tracking neuropathy progression.
- The Maxivibrometer is superior for research purposes requiring precise measurement of VPT, especially in advanced stages of diabetic neuropathy.